AbbVie
AbbVie Inc. is a prominent biopharmaceutical company based in the United States that was publicly traded and established in 2013. The company's inception stemmed from its spin-off from the renowned Abbott Laboratories.
Background[edit | edit source]
AbbVie's establishment in 2013 was a strategic move by Abbott Laboratories to separate its research-driven pharmaceutical business from its diversified medical products. The decision to spin off AbbVie aimed at allowing both entities to focus more exclusively on their individual business strategies and growth potentials.
Core Areas of Focus[edit | edit source]
AbbVie is committed to harnessing groundbreaking science to tackle some of the world's most complex and critical health challenges. Its primary areas of therapeutic focus include:
The company consistently invests in robust R&D initiatives to propel the boundaries of medicine and offer promising treatment avenues.
Notable Products[edit | edit source]
-6391.jpg)
AbbVie's portfolio boasts several groundbreaking and life-transforming drugs. Some of its flagship products include:
- Humira - An anti-inflammatory drug used for various conditions such as rheumatoid arthritis, psoriasis, and Crohn’s disease.
- Imbruvica - An oral, once-daily therapy mainly for patients with specific types of leukemia and lymphoma.
- Viekira Pak - A drug regimen used for the treatment of hepatitis C.
Global Presence[edit | edit source]
With a commitment to addressing complex health challenges, AbbVie has expanded its reach across the globe. It conducts business in more than 75 countries, ensuring that its life-saving treatments are accessible to patients worldwide.
Corporate Social Responsibility[edit | edit source]
Driven by its mission to have a remarkable impact on people's lives, AbbVie is heavily invested in community-centric programs, sustainable business practices, and initiatives aimed at reducing its carbon footprint.
See Also[edit | edit source]
References[edit | edit source]
- [1] AbbVie's Official History. Accessible at: https://www.abbvie.com/our-story.html
- [2] AbbVie's Therapeutic Areas of Focus. Retrieved from: https://www.abbvie.com/therapeutic-focus.html
- [3] AbbVie's Global Operations. Referenced from: https://www.abbvie.com/global-operations.html
| AbbVie Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
